Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools Reports First Quarter 2026 Financial Results
Reviewing Standard BioTools (NASDAQ:LAB) & Zhongchao (NASDAQ:ZCMD)
Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026
PPJ Enterprise (OTCMKTS:PPJE) and Standard BioTools (NASDAQ:LAB) Financial Comparison
Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial Results
Standard BioTools (LAB) Expected to Announce Quarterly Earnings on Tuesday
Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools (NASDAQ:LAB) versus Clover Health Investments (NASDAQ:CLOV) Critical Review
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Standard BioTools (NASDAQ:LAB) & Hinge Health (NYSE:HNGE) Critical Contrast
Analysts Set Standard BioTools Inc. (NASDAQ:LAB) Price Target at $1.35
Market Today: Stocks Rally, Tesla Robotaxi and Nvidia Scrutiny
Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass Cytometry
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks
Standard BioTools Reports Third Quarter 2025 Financial Results
Standard BioTools to Announce Third Quarter Financial Results on November 4, 2025
Illumina® Protein Prep launches to drive greater proteomic insights for improved drug discovery and development
Standard BioTools (LAB) Reports Q2 Loss, Tops Revenue Estimates
Standard BioTools Reports Second Quarter 2025 Financial Results
Standard BioTools and Precision Health Research, Singapore (PRECISE-SG100K) Launch Proteomics Collaboration, Selecting SomaScan to Power Large-Scale Population Health Study
Standard BioTools Schedules Second Quarter Earnings Conference Call on August 11, 2025
Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy
Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina
Standard BioTools to Host Inaugural “Proteomics Roundtable” Webcast Series
Standard BioTools Inc. (LAB) Q1 2025 Earnings Conference Call Transcript
Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue Estimates
Standard BioTools Reports First Quarter 2025 Financial Results
Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025
Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (LAB) Q4 2024 Earnings Call Transcript
Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results
Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue
Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Standard BioTools Appoints Alex Kim as Chief Financial Officer
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (LAB) Q3 2024 Earnings Call Transcript
Standard BioTools (LAB) Reports Q3 Loss, Tops Revenue Estimates
Standard BioTools Reports Third Quarter 2024 Financial Results
Standard BioTools Announces Conference Call and Webcast for Third Quarter 2024 Financial Results on October 30, 2024
GENOMMA LAB INTERNACIONAL ANNOUNCES NINTH DIVIDEND PAYMENT
Standard BioTools And 2 Other Penny Stocks Executives Are Buying
Standard BioTools And 3 Other Stocks Under $3 Executives Are Buying
Standard BioTools to Participate in Upcoming Investor Conferences
Standard BioTools Inc. (LAB) Q2 2024 Earnings Call Transcript
Standard BioTools (LAB) Reports Q2 Loss, Misses Revenue Estimates
Standard BioTools Announces Senior Leadership Changes